Ontology highlight
ABSTRACT: Background
Strongyloidiasis can cause devastating morbidity and death in immunosuppressed patients. Identification of reliable biomarkers for strongyloidiasis in immunosuppressed patients is critical for the prevention of severe disease.Methods
In this cross-sectional study of solid organ transplant (SOT) candidates and recipients, we quantified Strongyloides-specific IgG to the recombinant NIE-Strongyloides antigen and/or to a soluble extract of S. stercoralis somatic antigens ("crude antigen") using enzyme-linked immunosorbent assays (ELISAs). We also measured peripheral eosinophilia, 4 different eosinophil granule proteins, and intestinal fatty acid-binding protein (IFABP).Results
We evaluated serum biomarkers in 149 individuals; 77 (52%) pre-SOT and 72 (48%) pos
SUBMITTER: Clark E
PROVIDER: S-EPMC7744999 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature